Given the increased PPFIA4 expression in response to androgen deprivation in PCa cells and its role to promote CRPC progression, we hypothesized that blocking of PPFIA4-MTHFD2 axis in combination with new first-line endocrine therapy could be ideal to prevent CRPC progression. This evidence concerns the gene MTHFD2 and posterior cortical atrophy.